GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/phase 2 trial - New Study
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/phase 2 trial Summary This Phase 1/Phase 2 trial investigates the safety and efficacy of GD2-targeted CAR T cell therapy in patients with high-risk neuroblastoma, a challenging childhood cancer. Patients whose disease relapsed or was resistant to standard treatments received infusions of CAR T cells engineered to recognize the GD2…



















